A carregar...

Administration of a Nucleoside Analog Promotes Cancer Cell Death in a Telomerase-Dependent Manner

Telomerase, the end-replication enzyme, is reactivated in malignant cancers to drive cellular immortality. While this distinction makes telomerase an attractive target for anti-cancer therapies, most approaches for inhibiting its activity have been clinically ineffective. As opposed to inhibiting te...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Rep
Main Authors: Zeng, Xuehuo, Hernandez-Sanchez, Wilnelly, Xu, Mengyuan, Whited, Tawna L., Baus, Diane, Zhang, Junran, Berdis, Anthony J., Taylor, Derek J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6072277/
https://ncbi.nlm.nih.gov/pubmed/29874588
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.celrep.2018.05.020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!